APA (7th ed.) Citation

A, L., AH, M., A, H., LAA, G., & PI, S. (2024). Dupilumab-associated (hyper)eosinophilia in patients with atopic dermatitis: A single-centre cohort study of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry. The British journal of dermatology, 191(6), 1012. https://doi.org/10.1093/bjd/ljae289

Chicago Style (17th ed.) Citation

A, Li, Musters AH, Hyseni A, Gerbens LAA, and Spuls PI. "Dupilumab-associated (hyper)eosinophilia in Patients with Atopic Dermatitis: A Single-centre Cohort Study of the TREAT NL (TREatment of ATopic Eczema, the Netherlands) Registry." The British Journal of Dermatology 191, no. 6 (2024): 1012. https://doi.org/10.1093/bjd/ljae289.

MLA (9th ed.) Citation

A, Li, et al. "Dupilumab-associated (hyper)eosinophilia in Patients with Atopic Dermatitis: A Single-centre Cohort Study of the TREAT NL (TREatment of ATopic Eczema, the Netherlands) Registry." The British Journal of Dermatology, vol. 191, no. 6, 2024, p. 1012, https://doi.org/10.1093/bjd/ljae289.